Dela Cruz, Mrilou G.

HRN: 06-69-95  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/08/2026
CEFTRIAXONE 1G (VIAL)
03/08/2026
03/15/2026
IV
2g
OD
Uti
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary TractSkin & Soft Tissue    Compliance to guidelines: